Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

TriSalus Life Sciences (TLSI) Stock Forecast & Price Target

TriSalus Life Sciences logo
$3.15 +0.12 (+3.96%)
Closing price 04:00 PM Eastern
Extended Trading
$3.21 +0.06 (+2.03%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TriSalus Life Sciences - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
1
Buy
2

Based on 4 Wall Street analysts who have issued ratings for TriSalus Life Sciences in the last 12 months, the stock has a consensus rating of "Hold." Out of the 4 analysts, 1 has given a sell rating, 1 has given a hold rating, and 2 have given a buy rating for TLSI.

Consensus Price Target

$7.50
138.10% Upside
According to the 4 analysts' twelve-month price targets for TriSalus Life Sciences, the average price target is $7.50. The highest price target for TLSI is $8.00, while the lowest price target for TLSI is $7.00. The average price target represents a forecasted upside of 138.10% from the current price of $3.15.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for TLSI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TLSI Analyst Ratings Over Time

TypeCurrent Forecast
5/19/25 to 5/19/26
1 Month Ago
4/19/25 to 4/19/26
3 Months Ago
2/18/25 to 2/18/26
1 Year Ago
5/19/24 to 5/19/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.50$7.00$12.00$10.75
Forecasted Upside138.10% Upside50.54% Upside158.62% Upside107.53% Upside
Consensus RatingHoldHoldHoldBuy

TLSI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TLSI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

TriSalus Life Sciences Stock vs. The Competition

TypeTriSalus Life SciencesMedical CompaniesBroader Market
Consensus Rating Score
2.25
2.30
2.52
Consensus RatingHoldHoldModerate Buy
Predicted Upside147.52% Upside1,693.83% Upside17.05% Upside
News Sentiment Rating
Neutral News

See Recent TLSI News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/13/2026 DowngradeSell (D-)Sell (E+)
5/13/2026
Frank Takkinen
Frank Takkinen
2 of 5 stars
Lower TargetBuy$10.00 ➝ $8.00+237.55%
3/6/2026
William Plovanic
William Plovanic
3 of 5 stars
Lower TargetBuy$12.00 ➝ $7.00+57.66%
12/16/2025 UpgradeStrong SellHold
1/24/2025Reiterated RatingBuy$11.00 ➝ $11.00+112.60%
12/17/2024Initiated CoverageOverweight$10.00+157.73%
10/25/2024UpgradeStrong-Buy
9/16/2024 Initiated CoverageOutperform$10.00+121.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:21 PM ET.


TLSI Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for TriSalus Life Sciences is $7.50, with a high forecast of $8.00 and a low forecast of $7.00.

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TriSalus Life Sciences in the last year. There is currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TLSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLSI, but not buy additional shares or sell existing shares.

According to analysts, TriSalus Life Sciences's stock has a predicted upside of 138.10% based on their 12-month stock forecasts.

Over the previous 90 days, TriSalus Life Sciences's stock had 1 downgrade by analysts.

TriSalus Life Sciences has been rated by research analysts at Canaccord Genuity Group, Lake Street Capital, and Weiss Ratings in the past 90 days.

Analysts like TriSalus Life Sciences less than other "medical" companies. The consensus rating score for TriSalus Life Sciences is 2.25 while the average consensus rating score for "medical" companies is 2.30. Learn more on how TLSI compares to other companies.


This page (NASDAQ:TLSI) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners